Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion (NCT04679844)
A Prospective, Randomized, Multi-Center Study to Assess the Safety and Performance of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers (DBX or Grafton) Mixed With Local Autograft in Patients Undergoing One to Two-Level Instrumented Posterolateral Lumbar/Thoracolumbar Fusion (PLF)
🩺 Plain-English Summary (8th-Grade Level)
This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used by surgeons as a treatment for patients with degenerative disc disease or spinal trauma undergoing spinal fusion surgery. In this study, MagnetOs Easypack Putty will be used according to the latest U.S. Instructions For Use, standalone in the posterolateral spine.
Who can join: Review the eligibility criteria below.
Location: The Regents of the University of California- Irvine Campus — Irvine, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- The Regents of the University of California- Irvine Campus — Irvine, California
- Corewell Health — Grand Rapids, Michigan
- The Washington University — St Louis, Missouri
- Rothman Orthopaedic Institute — Philadelphia, Pennsylvania
- Tennessee Orthopaedic Alliance — Nashville, Tennessee
- University of Washington — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (970) 215-6793
Email: cesar.silva@kurosbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Degenerative Disc Disease
- Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. — Worcester, Massachusetts
- P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation — Birmingham, Alabama
- Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD — Phoenix, Arizona
- Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain — Phoenix, Arizona
- Investigation of DEXA-C Anterior Cervical Interbody System — Orange, California
- Assessing Safety of Cervical Spine Fusion With NMP® — Jasper, Alabama
Explore by condition: All Degenerative Disc Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.